Welcome to your daily briefing on healthcare developments in Maryland. Today we're covering 5 key stories including updates on maryland healthcare headlines, background & context. Let's dive in.
2 stories
The Maryland Board of Physicians has made its online Practitioner Profile Search available for verifying licensed healthcare practitioners in the state.
MD healthcare professionals can use this official tool to verify credentials, check disciplinary history, and ensure compliance with state licensing requirements.
The State of Maryland maintains an official webpage with Medicaid provider program resources and fee schedules.
Maryland healthcare professionals need current fee schedules and program resources to ensure proper reimbursement and compliance with state Medicaid requirements.
Reach healthcare professionals
3 stories
OSHA inspections of healthcare facilities most commonly find three violations: an Exposure Control Plan that has not been reviewed annually (date-stamped review required), engineering controls that have not been re-evaluated when new devices are introduced, and post-exposure protocols that do not match the actual reporting workflow.
Each citation carries per-violation penalties, and willful or repeat designations multiply them. Re-evaluation paperwork is the cheapest control to maintain.
A vendor is a business associate if they create, receive, maintain, or transmit PHI on behalf of the covered entity. They are NOT a business associate just because they happen to be in a building with PHI or could conceivably access it. The functional test matters, not the proximity test.
Forcing BAA execution on vendors who do not meet the functional test creates contractual bloat and weakens the negotiating position with vendors who actually do. Failing to execute BAAs with true business associates exposes the covered entity to OCR enforcement.
Covered entities must annually recertify their 340B eligibility through HRSA. Missing the recertification window pushes the entity to inactive status, which means immediate loss of 340B pricing and potentially diversion violations on previously dispensed drugs. Reinstatement requires a new application.
The discount value of 340B pricing for a covered entity often exceeds six figures annually. Letting the recertification lapse for paperwork reasons is one of the most expensive administrative errors in the regulation.
Get Maryland healthcare intelligence delivered to your inbox every morning.
Subscribe FreeView all past issues
Feature your brand across the U.S., Canada, and select international markets and 10 industry verticals.
Become a National Partner